EMEA Webinar - Accelerating Drug Discovery with 5D Multiomics
Date: Wednesday, July 30, 2025
Time: 11:00 AM CEST
In this two-part webinar, we’ll share how AVITI™ and AVITI24™ empower pharma teams to push the boundaries of discovery with speed, precision, and scalability.
First, Wilfred Van IJcken, Senior Technical Sales Specialist at Element Biosciences, will introduce AVITI24, the world’s first platform that integrates single cell and spatial detection of RNA, protein, and morphology and next-generation sequencing—all powered by our proprietary avidite base chemistry (ABC). With direct in sample sequencing (DISS) and no library prep, the novel ability of AVITI24 to generate multiomic data from intact samples makes it an ideal solution for teams seeking to reduce experimental complexity while gaining more actionable insights per run. This ultimately leads to deeper insights into disease biology, hit and biomarker identification, and mechanism of action to accelerate discovery.
Next, Daniel Alpern, Co-founder and CTO of Alithea Genomics, will share “High-Throughput Short-Turnaround Transcriptomics for Compound Screening and Lead Optimization: Scalable, Cost-Effective Insights into MOA and Toxicity”.
By capturing rich, transcriptome-wide signatures across hundreds of conditions, MERCURIUS™ DRUG-seq technology provides deep insights into mechanisms of action (MOA), off-target effects, and early toxicity signals. We’ll showcase how DRUG-seq combined with the AVITI platform enables high-throughput transcriptomic profiling of hundreds of treatment conditions at an unprecedented balance of cost and data quality. You’ll see how this integrated workflow enables data generation for 1000+ samples per run, short turnaround times, enhancing transcript detection, and isoform resolution critical to early decision-making. Whether you're scaling up transcriptomics for screening pipelines, transitioning to in-house sequencing, or seeking to reduce downstream attrition, this session will demonstrate how DRUG-seq and AVITI together deliver affordable, high-quality insights without compromising data quality.
Speakers:
 | Wilfred van IJcken |
 | Daniel Alpern Co-founder and CTO Alithea Genomics |